stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Victoryshares Us Eq Income Enhanced Volatility Wtd EtfCDC
$78.310.41%0.32

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC)

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Forecast

The Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $77.54, representing a -0.99% decrease from the current price of $78.31. The highest analyst price target is $79.66, and the lowest is $75.41.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month CDC Price Target
Average 77.53 (-1.00% Downside)

Is Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) A Buy Now?

Oscillators
NameValueAction
RSI(14)61.09Neutral
STOCH(9,6)55.14Neutral
STOCHRSI(14)38.21Neutral
MACD(12,26)0.97Buy
ADX(14)38.67Buy
William %R-36.12Neutral
CCI(14)27.04Neutral
Buy: 2 · Sell: 0 · Neutral: 5Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
77.90
Buy
77.66
Buy
MA20
76.94
Buy
76.88
Buy
MA50
75.06
Buy
75.85
Buy
MA100
75.69
Buy
75.16
Buy
MA200
73.95
Buy
73.40
Buy
Buy: 10 · Sell: 0 · Neutral: 0Summary: Buy

According to our latest analysis, CDC could be considered a Strong Buy, with 17 technical analysis indicators signaling 12 Buy signals, 0 signaling Sell signals and 5 Neutral signals. This might be a good time to open fresh positions on CDC, as trading bullish markets is always a lot easier

  1. RSI (Relative Strength Index): The RSI(14) value of 61.09 indicates that CDC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
  2. STOCH (Stochastic Oscillator): The STOCH value of 55.14 indicates that CDC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 38.21 indicates that CDC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 38.67 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of 27.04 indicates that CDC is not in oversold or overbought territory. It suggests a neutral sentiment in the short term.

Long-term CDC price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Victoryshares Us Eq Income Enhanced Volatility Wtd Etf financial reports and earnings history, Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) stock could reach $79.24 by 2030, $93.52 by 2040 and $127.65 by 2050. See the projected annual prices until 2050 of the Victoryshares Us Eq Income Enhanced Volatility Wtd Etf stock below:

  • Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) is expected to reach an average price of $89.88 in 2035, with a high prediction of $90.08 and a low estimate of $76.96. This indicates an +14.78% change from the last recorded price of $78.31.
  • Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) stock is projected to chart a bullish course in 2040, with an average price target of $91.51, representing an +16.86% change from its current level. The forecast ranges from a conservative $88.19 to a sky-high $93.52.
  • Our analysts predict Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) to change +28.37% by 2045, soaring from $99.69 to an average price of $100.53, potentially reaching $109.51. While $99.69 is the low estimate, the potential upside is significant.
  • Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) stock is expected to climb by 2050, reaching an average of $119.75, a +52.92% change from its current level. However, a wide range of estimates exists, with high and low targets of $127.65 and $113.08, respectively, highlighting the market's uncertainty.

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Year by Year Forecast

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Price Forecast for 2026

The predicted value for Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) in 2026 is set at an average of $74.48. Estimates vary from a peak of $79.66 to a trough of $65.52, indicating an -4.89% surge from the present price of $78.31.

MonthAverageLowHighChange from today's price
December, 2026$78.31$75.41$79.66+0.00%

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) is $78.55, with a high forecast of $85.10 and a low forecast of $69.96. This indicates an +0.30% increase from the last price of $78.31.

MonthAverageLowHighChange from today's price
January, 2027$82.19$76.94$82.42+4.96%
February, 2027$80.70$77.58$81.93+3.05%
March, 2027$80.96$76.93$81.86+3.39%
April, 2027$82.48$78.96$83.36+5.32%
May, 2027$80.10$79.99$85.10+2.29%
June, 2027$82.99$78.20$83.00+5.97%
July, 2027$74.08$73.50$82.89-5.41%
August, 2027$77.31$74.65$78.50-1.27%
September, 2027$80.00$77.04$80.08+2.15%
October, 2027$76.87$76.36$80.95-1.84%
November, 2027$71.17$69.96$79.16-9.12%
December, 2027$73.71$70.19$73.89-5.88%

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Price Forecast for 2028

In 2028, Victoryshares Us Eq Income Enhanced Volatility Wtd Etf (CDC) is projected to reach an average price of $70.86, with a high projection of $76.83 and a low estimate of $66.48. This indicates an -9.51% fall from the last price of $78.31.

MonthAverageLowHighChange from today's price
January, 2028$75.64$72.71$75.64-3.42%
February, 2028$72.98$71.41$76.15-6.81%
March, 2028$74.56$72.37$76.00-4.79%
April, 2028$75.21$74.32$76.83-3.96%
May, 2028$70.27$69.81$76.01-10.27%
June, 2028$71.79$68.16$72.02-8.33%
July, 2028$69.45$69.12$71.89-11.32%
August, 2028$68.33$67.56$69.93-12.74%
September, 2028$68.62$68.24$68.75-12.37%
October, 2028$69.30$68.43$69.41-11.51%
November, 2028$66.77$66.48$69.31-14.73%
December, 2028$67.40$67.01$67.94-13.93%

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Price Forecast for 2029

The 2029 price forecast for Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) is $68.78 on average, with a high prediction of $73.82 and a low estimate of $65.73. This represents an -12.17% decrease from the previous price of $78.31.

MonthAverageLowHighChange from today's price
January, 2029$66.39$66.35$67.52-15.22%
February, 2029$66.55$66.21$67.07-15.01%
March, 2029$67.49$66.48$67.52-13.81%
April, 2029$67.91$67.45$68.30-13.28%
May, 2029$67.00$65.81$68.23-14.44%
June, 2029$67.89$65.73$68.14-13.31%
July, 2029$69.52$67.31$69.95-11.22%
August, 2029$68.94$67.50$70.98-11.96%
September, 2029$70.89$68.82$71.10-9.48%
October, 2029$69.18$68.96$71.83-11.65%
November, 2029$71.34$69.03$71.57-8.90%
December, 2029$72.21$71.17$73.82-7.79%

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) Price Forecast for 2030

Victoryshares Us Eq Income Enhanced Volatility Wtd Etf Stock (CDC) is expected to reach an average price of $75.04 in 2030, with a high forecast of $79.24 and a low forecast of $68.97. This signifies an -4.17% decrease from the last price of $78.31.

MonthAverageLowHighChange from today's price
January, 2030$74.35$72.01$75.64-5.06%
February, 2030$76.42$73.30$76.43-2.42%
March, 2030$76.18$75.51$77.49-2.72%
April, 2030$78.41$75.14$78.61+0.12%
May, 2030$73.94$73.00$79.24-5.58%
June, 2030$72.98$72.91$74.70-6.81%
July, 2030$76.43$72.97$76.87-2.40%
August, 2030$75.77$72.81$78.33-3.24%
September, 2030$71.93$68.97$77.35-8.15%
October, 2030$74.28$71.35$74.29-5.15%
November, 2030$74.45$73.27$75.60-4.93%
December, 2030$75.38$73.90$75.41-3.74%

Similar to CDC